Scarica l'app Stockscreener
0.4065
11.89%
0.0432
Precedente Chiudi:
$0.3633
Aprire:
$0.365
Volume 24 ore:
783.67K
Relative Volume:
0.11
Capitalizzazione di mercato:
$370.46M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.0326
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
-7.61%
1M Prestazione:
-33.26%
6M Prestazione:
-94.83%
1 anno Prestazione:
-94.76%
Intervallo 1D:
$0.3528
$0.4196
Intervallo di 1 settimana:
$0.3528
$0.4634
Portata 52W:
$0.3528
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Nome
Kala Bio Inc
Settore
Industria
Telefono
781-996-5252
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.4065 | 331.09M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Iniziato | Mizuho | Outperform |
| 2025-07-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-07-23 | Iniziato | Northland Capital | Outperform |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2020-05-27 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Kala Bio Inc Borsa (KALA) Ultime notizie
Can KALA BIO Inc. outperform under higher oil pricesRecession Risk & Weekly Hot Stock Watchlists - mfd.ru
Can KALA BIO Inc. be the next market leader2025 Winners & Losers & AI Powered Trade Plan Recommendations - mfd.ru
Market Catalysts: Is KALA BIO Inc part of any major indexQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
KALA to Offer 241.44 Million Shares in New Stock Sale - GuruFocus
Macro Review: Can KALA BIO Inc stock outperform in a bear market2025 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
KALA BIO (KALA) names director Avi Minkowitz CEO and CFO as David Lazar steps down - Stock Titan
KALA BIO, Inc. Announces Chief Executive Officer Changes, Effective February 2, 2026 - marketscreener.com
Bearish Setup: Can Arm Holdings plc Depositary Receipt outperform under higher oil pricesRate Hike & Scalable Portfolio Growth Methods - baoquankhu1.vn
KALA BIO expands preferred financing and shareholder authorizations - TipRanks
KALA BIO Signs Securities Purchase Agreement With Series AAA Investors - TradingView
KALA: All proposals, including director elections and share increases, passed with no stockholder questions - TradingView
KALA: All proposals, including director elections and share increase, passed unanimously - TradingView
KALA BIO Receives Nasdaq Notice on Listing Compliance - TipRanks
KALA Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Aug EndMonth: Is Codere Online Luxembourg SAs ROIC above industry averagePortfolio Performance Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Trading Action: Can LOAN weather a recessionTrade Risk Report & Low Risk Entry Point Tips - baoquankhu1.vn
KALA Stock Price, Forecast & Analysis | KALA BIO INC (NASDAQ:KALA) - Chartmill
Can KALA BIO Inc stock outperform in a bear marketWeekly Profit Analysis & Breakout Confirmation Trade Signals - baoquankhu1.vn
Why KALA BIO Inc stock is a must watch in 2025July 2025 PostEarnings & Community Driven Trade Alerts - Bộ Nội Vụ
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction - MSN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
KALA BIO Launches At-the-Market Equity Offering Program - TipRanks
Why hedge funds are buying KALA BIO Inc. stockPortfolio Growth Summary & Risk Adjusted Swing Trade Ideas - Улправда
Can KALA BIO Inc. stock weather global recessionJuly 2025 Final Week & Real-Time Chart Breakout Alerts - Улправда
KALA BIO eliminates debt overhang through equity settlements - TipRanks
KALA BIO Signs Multiple Material Agreements - TradingView — Track All Markets
KALA BIO Clears Oxford DebtA Fresh Start Ahead? - Nasdaq
Kala Bio Settles $10.6 Million Debt; Shares Rise After-Hours - MarketScreener
Kala Bio settles $10.6 million debt with Oxford Finance By Investing.com - Investing.com Nigeria
Kala Bio Settles Approximately $10.6 Million Of Debt - TradingView — Track All Markets
Kala Bio settles $10.6 million debt with Oxford Finance - Investing.com
KALA BIO Settles Approximately $10.6 million of Debt - The Manila Times
Kala Bio fully settles loan, strengthens balance sheet - MSN
Kala Bio Inc pays $2 million to Oxford Finance LLC as part of settlement agreement - marketscreener.com
KALA BIO Announces Conditional Resignations of Six Directors - TradingView — Track All Markets
KALA BIO Directors Plan Conditional Resignations Tied to Vote - TipRanks
Top Penny Stocks To ResearchDecember 4th - MarketBeat
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga
Support Test: What insider trading reveals about AAOI stockJuly 2025 Sentiment & High Return Trade Guides - moha.gov.vn
Market Review: How KALA BIO Inc. stock trades before earnings2025 Winners & Losers & Short-Term Swing Trade Alerts - Улправда
Will KALA BIO Inc. stock see PE expansion2025 Growth vs Value & High Win Rate Trade Tips - Улправда
How KALA BIO Inc. stock reacts to bond yieldsJuly 2025 Big Picture & Precise Buy Zone Identification - DonanımHaber
Can KALA BIO Inc. stock deliver sustainable ROEMarket Weekly Review & Growth Focused Stock Reports - DonanımHaber
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Risk Check: Will KALA BIO Inc. stock see PE expansionRisk Management & Fast Exit and Entry Trade Guides - Улправда
How KALA BIO Inc. stock trades before earningsWeekly Market Report & Consistent Income Trade Recommendations - ulpravda.ru
Kala Bio Stock Slides 42% With A 8-Day Losing Spree - Trefis
KALA BIO Announces New CEO and Funding Deal - The Globe and Mail
Oxford Finance Llc Net Worth (2025) - GuruFocus
Kala Bio dismisses Deloitte as auditor, no successor named By Investing.com - Investing.com Canada
Kala Bio Inc Azioni (KALA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kala Bio Inc Azioni (KALA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 22 '25 |
Sale |
0.83 |
32,230 |
26,751 |
29,873 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 23 '25 |
Sale |
0.82 |
967 |
793 |
28,906 |
| Bazemore Todd | Director |
Oct 22 '25 |
Sale |
0.83 |
47,768 |
39,647 |
35,932 |
| Brazzell Romulus K | SEE REMARKS |
Oct 22 '25 |
Sale |
0.83 |
46,748 |
38,801 |
35,952 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Oct 22 '25 |
Sale |
0.83 |
20,806 |
17,269 |
41,760 |
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):